Botanix Pharmaceuticals Limited (ASX:BOT)
Australia · Delayed Price · Currency is AUD 0.0190
-0.0010 (-5.00%)
Jul 31, 2026, 4:10 PM AEST
Botanix Pharmaceuticals Stock Forecast
ASX-BOT's stock price has decreased by -87.74% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, Botanix Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $0.49. The average 1-year stock price forecast is 2,478.95% higher than the current stock price, while the lowest is $0.14 (+636.84%) and the highest is $1.00 (+5,163.16%).
Price Target: $0.49 (+2,478.95%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Botanix Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $1.00 | Buy | Reiterates | $1.00 | +5,163.16% | Jul 27, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $0.14 | Buy | Maintains | $0.14 | +636.84% | May 4, 2026 |
Financial Forecast
Revenue This Year
35.95M
from 5.79M
Increased by 520.98%
Revenue Next Year
63.80M
from 35.95M
Increased by 77.47%
EPS This Year
-0.02
from -0.05
EPS Next Year
-0.01
from -0.02
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.